Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment.
Clinical trial NCT02624557 · COMPLETED
Trial details
- NCT number
- NCT02624557
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-21
- Primary completion
- 2017-10-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.